Quoin Pharma announces 1-for-20 reverse ADS split to regain Nasdaq compliance

Quoin Pharmaceuticals, Ltd.

ADS ratio changed from 1:1 to 1:20 (one ADS now represents 20 ordinary shares) effective April 8, 2025.
Reverse split automatically converts every 20 existing ADSs into 1 new ADS; ordinary shares unchanged.
New CUSIP number for ADSs is 74907L409; ticker QNRX remains on Nasdaq Capital Market.
Objective is to increase ADS per-share price above $1.00 minimum bid to avoid delisting.
Company cannot guarantee that the ratio change will achieve or sustain Nasdaq compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.